Beclin-1 and LC3A expression in cutaneous malignant melanomas: A biphasic survival pattern for beclin-1

Melanoma Research

Volumn 21, Issue 3, 2011, Pages 188-195

  Sivridis, Efthimios ^a   Koukourakis, Michael I ^a   Mendrinos, Savvas E ^b   Karpouzis, Antonios ^a   Fiska, Aliki ^a   Kouskoukis, Constantinos ^a   Giatromanolaki, Alexandra ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

autophagy; beclin 1; cutaneous malignant melanoma; hypoxia; light chain 3A

Indexed keywords

BECLIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE 5; MEMBRANE PROTEIN; PROTEIN LC3A; UNCLASSIFIED DRUG;

ADULT; ANAEROBIC GLYCOLYSIS; ANGIOGENESIS; ARTICLE; AUTOPHAGY; CANCER SURVIVAL; CELL ORGANELLE; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; ULCER;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL HYPOXIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 79955606244     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328346612c     Document Type: Article

References (74)

1. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007; 82:364-380. (Pubitemid 46348938)
2. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer: the role of sunlight. Adv Exp Med Biol 2008; 624:89-103.
3. Duncan LM. The classification of cutaneous melanoma. Hematol Oncol Clin North Am 2009; 23: 501-513. ix.
4. Norval M, Cullen AP, de Gruijl FR, Longstreth J, Takizawa Y, Lucas RM, et al. The effects on human health from stratospheric ozone depletion and its interactions with climate change. Photochem Photobiol Sci 2007; 6:232-251. (Pubitemid 46385676)
5. Thörn M, Pontén F, Bergström R, Sparén P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst 1994; 86:761-769. (Pubitemid 24152891)
6. Slominski A, Ross J, Mihm MC. Cutaneous melanoma: pathology, relevant prognostic indicators and progression. Br Med Bull 1995; 51:548-569.
7. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001; 19:3622-3634. (Pubitemid 32786275)
8. McGovern VJ, Shaw HM, Milton GW, Farago GA. Prognostic significance of the histological features of malignant melanoma. Histopathology 1979; 3:385-393. (Pubitemid 10232134)
9. Heenan PJ, English DR, Holman CD, Armstrong BK. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981. Cancer 1991; 68:2079-2087.
10. Barnhill RL, Fine JA, Roush GC, Berwick M. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study. Cancer 1996; 78:427-432. (Pubitemid 26250527)
11. Halpern AC, Schuchter LM. Prognostic models in melanoma. Semin Oncol 1997; 24 (1 Suppl 4):S2-S7.
12. Clark WH Jr, Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81:1893-1904. (Pubitemid 20026075)
13. Naruns PL, Nizze JA, Cochran AJ, Lee MB, Morton DL. Recurrence potential of thin primary melanomas. Cancer 1986; 57:545-548. (Pubitemid 16164607)
14. Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanomas (less that 0.76 mm). Ann Surg 1983; 198:63-64. (Pubitemid 13059119)
15. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. Am J Pathol 1994; 145:510-514. (Pubitemid 24285957)
16. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
17. Eisenberg-Lerner A, Kimchi A. The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 2009; 14:376-391.
18. Zois CE, Koukourakis MI. Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies? Autophagy 2009; 5:442-450.
19. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003; 9:685-693. (Pubitemid 36749217)
20. Vaupel P, Thews O, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001; 18:243-259. (Pubitemid 34044509)
21. Harris AL. Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2:38-47. (Pubitemid 37328806)
22. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res 2000; 60:6201-6207.
23. Esumi H, Izuishi K, Kato K, Hashimoto K, Kurashima Y, Kishimoto A, et al. Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5-AMP-activated protein kinase-dependent manner. J Biol Chem 2002; 277:32791-32798. (Pubitemid 34984788)
24. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct 2002; 27:421-429. (Pubitemid 36267711)
25. Martinet W, De Meyer GRY, Andries L, Herman AG, Kockx MM. In-situ detection of starvation-induced autophagy. J Histochem Cytochem 2006; 54:85-96.
26. Bhattacharyya TK, Buttler DG. Ultrastructure of the adrenocortical homologue in dexamethasone-treated eels. J Anat 1980; 130:323-332. (Pubitemid 10105622)
27. Fedorko M. Effect of chloroquine on morphology of cytoplasmic granules in maturing human leukocytes: an ultrastructural study. J Clin Invest 1967; 12:1932-1942.
28. Hickman S, Neufeld EF. A hypothesis for I-cell disease: defective hydrolases that do not enter lysosomes. Biochem Biophys Res Comm 1972; 49:992-999.
29. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19:5720-5728.
30. He H, Dang Y, Dai F, Guo Z, Wu J, She X, et al. Post-translational modifications of three members of the human MAP1LC3 family and detection of a novel type of modification for MAP1LC3B. J Biol Chem 2003; 278:29278-29287. (Pubitemid 36935844)
31. Cao Y, Klionsky DJ. Physiological functions of Atg6/beclin 1: a unique autophagy-related protein. Cell Res 2007; 17:839-849. (Pubitemid 47585112)
32. Giatromanolaki A, Sivridis E, Kouskoukis C, Gatter KC, Harris AL, Koukourakis MI. Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res 2003; 13:493-501. (Pubitemid 37266952)
33. Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer 2010; 103:1209-1214.
34. Sivridis E, Koukourakis MI, Zois CE, Ledaki I, Ferguson DJ, Harris AL, et al. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol 2010; 176:2477-2489.
35. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Lactate dehydrogenase 5 expression in operable colorectal cancer. Strong association with survival and activated vascular endothelial growth factor pathway: a report of the Tumour Angiogenesis Research Group. J Clin Oncol 2006; 24:4301-4308. (Pubitemid 46630788)
36. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, et al. Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999; 59:59-65. (Pubitemid 29339873)
37. Karantza-Wadsworth V, White E. Role of autophagy in breast cancer. Autophagy 2007; 3:610-613.
38. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-1820. (Pubitemid 38063704)
39. Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, et al. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009; 5:303-306.
40. Shi YH, Ding ZB, Zhou J, Qiu SJ, Fan J. Prognostic significance of beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy 2009; 5:380-382.
41. Subarsky P, Hill RP. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 2003; 20:237-250. (Pubitemid 36513228)
42. Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004; 4:437-447. (Pubitemid 38745529)
43. Chang SH, Worley LA, Onken MD, Harbour JW. Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis. Melanoma Res 2008; 18:191-200. (Pubitemid 351684664)
44. Levine B, Yuan J. Autophagy in cell death: an innocent convict? J Clin Invest 2005; 115:2679-2688. (Pubitemid 41434392)
45. Zhang H, Bosch-Marce M, Shimoda LA, Tan YS, Baek JH, Wesley JB. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolicresponse to hypoxia. J Biol Chem 2008; 283: 10892-10903.
46. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29:2570-2581.
47. Chen Y, Lu Y, Lu C, Zhang L. Beclin 1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression. Pathol Oncol Res 2009; 15:487-493.
48. Ahn CH, Jeong EG, Lee JW, Kim MS, Kim SH, Kim SS, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007; 115:1344-1349.
49. Yoshioka A, Miyata H, Doki Y, Yamasaki M, Sohma I, Gotoh K, et al. LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int J Oncol 2008; 33:461-468.
50. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-676. (Pubitemid 129516338)
51. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, et al. Protein and mRNA expression of autophagy gene beclin 1 in human brain tumours. Int J Oncol 2007; 30:429-436.
52. Shen Y, Li DD, Wang LL, Deng R, Zhu XF. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008; 4:1067-1068.
53. Ding ZB, Shi YH, Zhou J, Qiu SJ, Xu Y, Dai Z, et al. Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinoma. Cancer Res 2008; 68:9167-9175.
54. Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, Marsili S, et al. The prognostic role of beclin 1 protein expression in high-grade gliomas. Autophagy 2009; 5:930-936.
55. Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 2010; 41:503-512.
56. Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X, et al. Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells. Autophagy 2009; 5:816-823.
57. Straume O, Salvesen HB, Akslen LA. Angiogenesis is prognostically important in vertical growth phase melanomas. Int J Oncol 1999; 15:595-599.
58. Gulliksrud K, Vestvik IK, Galappathi K, Mathiesen B, Rofstad EK. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry. Radiat Res 2008; 170:638-650.
59. Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002; 62:1847-1853. (Pubitemid 34408512)
60. Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products. Cancer Res 2005; 65:2387-2396. (Pubitemid 40490150)
61. Bedogni B, Welford SM, Cassarino DS, Nickolloff BJ, Giaccia AJ, Powell MB. The hypoxic microenvironment of the skin contributes to Aktmediated melanocyte transformation. Cancer Cell 2005; 8:443-454. (Pubitemid 41773448)
62. Samokhvalov V, Scott BA, Crowder CM. Autophagy protects against hypoxic injury in C. elegans. Autophagy 2008; 4:1034-1041.
63. Fujii S, Mitsunaga S, Yamazaki M, Hasebe T, Ishii G, Kojima M, et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 2008; 99:1813-1819.
64. Liu Q, Wang JJ, Pan YC, Meng LF, Zhan X, Zheng QF. Expression of autophagy-related genes beclin 1 and MAPLC3 in non-small cell lung cancer. Ai Zheng 2008; 27:25-29.
65. Aoki H, Kondo Y, Aldape K, Yamamoto A, Iwado E, Yokoyama T, et al. Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 2008; 4:467-475. (Pubitemid 351705143)
66. Farrall AL, Whitelaw ML. The HIF1alpha-inducible pro-cell death gene BNIP3 is a novel target of SIM2s repression through cross talk on the hypoxia response element. Oncogene 2009; 28:3671-3680.
67. Sivridis E, Giatromanolaki A, Zois C, Koukourakis MI. The 'stone-like' pattern of autophagy in human epithelial tumors and tumor-like lesions: an approach to the clinical outcome. Autophagy 2010; 6:830-833.
68. Giatromanolaki A, Koukourakis MI, Harris AL, Polychronidis A, Gatter KC, Sivridis E. Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol 2010; 63:867-872.
69. Sivridis E, Giatromanolaki A, Liberis V, Koukourakis MI. Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS) What is destined for the atypical endometrial hyperplasia? Autophagy 2011; 7:74-82.
70. Karpathiou G, Sivridis E, Koukourakis M, Mikroulis D, Bouros D, Froudarakis M, Giatromanolaki A. LC3A autophagic activity and prognostic significance in non-small cell lung carcinomas. Chest 2011; doi: 10.1378/chest.10-1831. [Epub ahead of print]
71. Sivridis E, Giatromanolaki A, Karpathiou G, Karpouzis A, Kouskoukis C, Koukourakis MI. LC3A-positive 'stone-like' structures in cutaneous squamous cell carcinomas. Am J Dermatopathol 2011. [Epub ahead of print]
72. Mizushima N. Methods for monitoring autophagy. Int J Biochem Cell Biol 2004; 36:2491-2502. (Pubitemid 39119761)
73. Hippert MM, O'Toole PS, Thorburn A. Autophagy in cancer: good, bad, or both? Cancer Res 2006; 66:9343-9351.
74. Sato K, Tsuchihara K, Fujii S, Sugiyama M, Goya T, Atomi Y, et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res 2007; 67:9677-9684. (Pubitemid 47621214)